Fairtree Asset Management Pty Ltd acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,939 shares of the company’s stock, valued at approximately $1,146,000.
A number of other hedge funds also recently bought and sold shares of the business. Brighton Jones LLC purchased a new stake in HCA Healthcare during the fourth quarter valued at approximately $1,021,000. NewEdge Advisors LLC raised its holdings in HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares during the period. Sivia Capital Partners LLC boosted its stake in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares during the period. Jump Financial LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at $2,073,000. Finally, Sei Investments Co. boosted its stake in shares of HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after purchasing an additional 49,214 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Wall Street Analyst Weigh In
HCA has been the subject of several analyst reports. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research note on Monday, July 27th. Barclays cut their price objective on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research report on Monday, July 27th. Stephens lowered their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Wells Fargo & Company lifted their price objective on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Finally, Mizuho dropped their target price on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 28th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $462.64.
HCA Healthcare Trading Down 0.2%
HCA opened at $406.33 on Friday. The company has a market capitalization of $87.97 billion, a price-to-earnings ratio of 13.60, a PEG ratio of 1.41 and a beta of 1.10. The business’s fifty day simple moving average is $396.32 and its 200-day simple moving average is $444.25. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.84 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s payout ratio is 10.45%.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
